Cumulative number of COVID-19 vaccinations South Korea 2022, by manufacturer

As of May 3, 2022, around 76.6 million Pfizer COVID-19 vaccines had been administered in South Korea. Other major vaccines included Moderna with around 24.5 million doses, and AstraZeneca with around 20.3 million doses. In 2021, the South Korean government announced a COVID-19 vaccination plan for employees under the age of 65 in nursing hospitals or facilities, high-risk medical institutions, and the first responding group including emergency personnel or quarantine personnel, etc. The AstraZeneca vaccine was to be used for this priority group and the vaccination was scheduled to take place from February until May. Furthermore, vaccinations were planned for staff in hospitals treating COVID-19 patients, and the Pfizer vaccine was to be used for this group. South Korea's handling of the coronavirus (COVID-19) was initially widely praised, though the government's handling of vaccine distribution has been criticized.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.